We are live on
!
Find out more
HI
Humankind Investments Portfolio holdings
AUM
$175M
1-Year Est. Return
14.3%
This Fund
S&P 500
This Quarter
Est. Return
-2.4%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
–
AUM
$244M
AUM Growth
+$165M
(+208%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
65.83%
Top 10 Holdings %
Top 10 Hldgs %
66.41%
Holding
119
New
13
Increased
60
Reduced
45
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HKND
Humankind US Stock ETF
HKND
|
+$73.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$18M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$13.9M |
| 4 |
Apple
AAPL
|
+$13.3M |
| 5 |
Microsoft
MSFT
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$303K |
| 2 |
THS
Treehouse Foods
THS
|
+$221K |
| 3 |
McKesson
MCK
|
+$206K |
| 4 |
Thermo Fisher Scientific
TMO
|
+$200K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$172K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 12.65% |
| 3 | Consumer Staples | 5.56% |
| 4 | Communication Services | 4.92% |
| 5 | Materials | 3.48% |
Similar funds
MWM
BCVI
OA
LTL
AWMM
CC
BW
DWA
Humankind Investments's Q1 2022 Portfolio in Review
As of Q1 2022, Humankind Investments held 119 positions worth $244M, up 208% from $79.4M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Humankind Investments deployed $161M of net new capital in Q1 2022, opening 13 new positions and adding to 60 existing holdings. Its largest new stake was Humankind US Stock ETF: 2,539,178 shares worth $74.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was AbbVie, an estimated $303K trimmed.
- Humankind Investments's largest Q1 2022 buy was Humankind US Stock ETF: 2,539,178 shares worth $74.7M.
- Humankind Investments added most to Alphabet (Google) Class A in Q1 2022, an estimated $685K increase.
- Humankind Investments's biggest Q1 2022 reduction was AbbVie, cutting an estimated $303K.
- Humankind Investments fully exited Treehouse Foods in Q1 2022, selling an estimated $221K.
- Humankind Investments's ten largest holdings make up 66% of its $244M portfolio in Q1 2022.
- Humankind Investments opened 13 new positions and closed 1 in Q1 2022.
- Humankind Investments's portfolio value rose 208% quarter-over-quarter to $244M.
Based on Humankind Investments's 13F filing for Q1 2022, filed 9 May 2022.